EAGAN, Minn., Oct. 20, 2026 /PRNewswire/ — ABM Respiratory Care (“ABMRC”), a medical technology company developing innovative respiratory care solutions for hospital and home use, today announced that it has secured a $20 million growth capital commitment from Trinity Capital Inc. (NYSE: TRIN), an international alternative asset manager.

The financing will support ABMRC’s next phase of growth, with a focus on accelerating commercial expansion, strengthening its presence in existing and new markets, and advancing product innovation, clinical research, and connected respiratory care technologies.

“This financing represents an important milestone in ABM Respiratory Care’s continued growth,” said Greg Miller, Chief Executive Officer of ABM Respiratory Care. “Our partnership with Trinity Capital provides additional capital and flexibility to expand our commercial reach, build on the momentum of our BiWaze platform, and invest in technologies that support the evolving needs of patients and healthcare providers worldwide.”

ABMRC’s BiWaze^® platform includes two FDA-cleared respiratory therapy systems that address distinct airway clearance needs. BiWaze^® Clear delivers oscillating lung expansion therapy designed to mobilize secretions and support airway clearance in the lower airways, while BiWaze^® Cough provides mechanical insufflation-exsufflation therapy to assist patients with an ineffective cough in clearing secretions. Both technologies are designed for use across hospital and home care settings. The company continues to expand commercial access to these therapies while advancing clinical research and its Arc Connect™ digital health platform, designed to support patient engagement, therapy tracking, and greater visibility into respiratory therapy utilization for care teams.

“We are pleased to partner with ABM Respiratory Care as the company enters its next phase of growth,” said Rob Lake, Senior Managing Director, Healthcare & Life Sciences at Trinity Capital. “We believe in the company’s technology and its vision for expanding access to respiratory care solutions.”

About ABM Respiratory Care

Founded in 2017, ABM Respiratory Care is dedicated to advancing patient care by developing intelligent, clinically differentiated respiratory care solutions to help people breathe better inside and outside the hospital. The company’s connected platform is designed to improve respiratory therapy by promoting deeper breathing, enhancing oxygen exchange, reducing aerosol emission exposure, and enabling communication for better disease management across all care settings. For more information, visit www.abmrc.com.

About Trinity Capital Inc.

Trinity Capital Inc. (NYSE: TRIN) is an international alternative asset manager that seeks to deliver consistent returns for investors through access to private credit markets. Trinity Capital sources and structures investments in well-capitalized growth-oriented companies across five distinct lending verticals: Tech Lending, Equipment Finance, Healthcare & Life Sciences, Sponsor Finance, and Asset Based Lending. As a long-term, trusted partner for innovative companies seeking tailored debt solutions, Trinity Capital has deployed more than $6.2 billion across over 490 investments since inception in 2008 (as of June 30, 2026). Headquartered in Phoenix, Arizona, Trinity Capital’s dedicated team is strategically located across the United States and Europe. For more information on Trinity Capital, please visit trinitycapital.com and stay connected to the latest activity via LinkedIn.

Media Contact

Leah Noaeill
Vice President, Marketing & Clinical Affairs
ABM Respiratory Care
Leah.Noaeill@abmrc.com
www.abmrc.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/abm-respiratory-care-secures-20-million-financing-from-trinity-capital-to-accelerate-commercial-expansion-302913360.html

SOURCE ABM Respiratory Care